Medical Subject Headings

Last uploaded: January 16, 2025

Id	http://purl.bioontology.org/ontology/MESH/C000629483 http://purl.bioontology.org/ontology/MESH/C000629483
Preferred Name	adafosbuvir
Synonyms	AL-335 propan-2-yl N-((P5'S)-4'-fluoro-2'-C-methyl-p-o-phenyl-5'-uridylyl)-L-alaninate
Type	http://www.w3.org/2002/07/owl#Class

altLabel	AL-335 propan-2-yl N-((P5'S)-4'-fluoro-2'-C-methyl-p-o-phenyl-5'-uridylyl)-L-alaninate
prefLabel	adafosbuvir
TH	FDA SRS (2017) NLM (2019) USAN (19XX) INN (19XX)
notation	C000629483
PA	D000998
MMR	20201123
MeSH Frequency	6
Semantic type UMLS property	http://purl.bioontology.org/ontology/STY/T121 http://purl.bioontology.org/ontology/STY/T109
HM	D000409/Q000031 D063088 D014529/Q000031
Inverse of RB	S83770Y75R
Scope Statement	a hepatitis C virus (HCV) NS5B inhibitor
MDA	20190109
SC	1
type	http://www.w3.org/2002/07/owl#Class
Mapped to	http://purl.bioontology.org/ontology/MESH/D063088 http://purl.bioontology.org/ontology/MESH/D000409 http://purl.bioontology.org/ontology/MESH/D014529
Has mapping qualifier	http://purl.bioontology.org/ontology/MESH/Q000031
tui	T109 T121
SRC	Pharmacol Res Perspect. 2018 Apr 30;6(3):e00395.
cui	C5198614 C5139767
isa	http://purl.bioontology.org/ontology/MESH/D000998
TERMUI	T000950383 T000950382 T000950381

Delete	Subject	Author	Type	Created
No notes to display